Dianthus Therapeutics, Inc. /DE/

Ownership Transactions Reported by 32 Insiders

Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
7 Times Square, 43 Rd Floor, New York, NY

Insiders trading volume in the past year

Dianthus Therapeutics, Inc. /DE/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lei Meng Director $54.6M Jan 22, 2024
Fairmount Funds Management LLC Director $42.4M Sep 27, 2024
Third Rock Ventures IV, L.P. 10%+ Owner $36.7M Feb 7, 2023
Leon O. Moulder Jr Director $17.2M May 23, 2024
Jason Gardner Title: President and Chief Executive Officer, Director $11.3M Nov 30, 2022
Kristen Stants Chief People Officer $243K Nov 30, 2022
Thomas W. Beetham Title: Chief Legal Officer and Secretary $239K Nov 30, 2022
Caren Deardorf Chief Commercial Officer $237K Nov 30, 2022
Stephen F. Mahoney Title: Chief Financial and Operating Officer $207K Nov 30, 2022
David Wayne Nichols Chief Technical Officer $172K Aug 1, 2022
Lisa Olson Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney $171K Aug 1, 2022
Alexis Borisy Director $49.2K Aug 26, 2021
Ryan Savitz Cfo & Cbo $0 -$700K -100% Sep 23, 2025
Sujay Kango Director Mar 4, 2025
Steven J. Romano Director May 22, 2025
Anne McGeorge Director May 22, 2025
Simrat Randhawa Chief Medical Officer Sep 23, 2025
Alison Frances Lawton Director May 22, 2025
Paula Soteropoulos Director May 22, 2025
Adam M. Veness SVP, General Counsel and Sec. Feb 3, 2025
Edward Carr Chief Accounting Officer Feb 3, 2025
Jonathan Violin Director May 22, 2025
Marino Garcia CEO AND PRESIDENT, Director Sep 30, 2025
Simon Read Director May 22, 2025
David Scadden Director Jun 28, 2022
Bruce Booth Director Jun 28, 2022
Michael Vasconcelles Director Aug 15, 2022
Thomas O. Daniel Director Jun 28, 2022
Jeffrey W. Albers Director Jun 28, 2022
Jeffrey Humphrey Chief Medical Officer Aug 1, 2022
Michael W. Bonney Director Jun 1, 2021
Amy L. Ronneberg Director Jun 28, 2022

Recent Insider Transactions by Companies or Individuals for Dianthus Therapeutics, Inc. /DE/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.